SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

NeOnc Technologies Reschedules FDA Meeting on Cancer Drug

NeOnc Technologies said its meeting with the FDA on a cancer drug was rescheduled. Shares fell.

NTHI

Related stories